TORONTO—Canadian neurosurgeons in partnership with Elon Musk’s Neuralink have regulatory approval to recruit six patients with paralysis willing to have a thousand electrode contacts in their brains.
The trial, called CAN-PRIME, has started recruiting patients for a study that will test the safety and efficacy of a device that allows people to move cursors with their minds, a surgeon leading the trial said.
Neuralink announced regulator Health Canada’s approval this week. Neuralink has implanted two such devices in patients in the United States.
Directors at Neuralink reached out to Toronto-based University Health Network neurosurgeon Andres Lozano a year ago, he told Reuters. He figures his experience with other forms of brain implants played a role….